Short Interest in Itonic Holdings Ltd. (NASDAQ:ITOC) Decreases By 59.0%

Itonic Holdings Ltd. (NASDAQ:ITOC) was the recipient of a large drop in short interest in the month of June. As of June 15th, there was short interest totaling 81,183 shares, a drop of 59.0% from the May 31st total of 197,966 shares. Based on an average trading volume of 3,686,350 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.5% of the company’s stock are sold short.

Itonic Trading Up 3.0%

Shares of ITOC stock opened at $0.31 on Wednesday. Itonic has a fifty-two week low of $0.25 and a fifty-two week high of $32.00. The business has a 50-day moving average price of $0.33.

Itonic (NASDAQ:ITOC) last released its quarterly earnings data on Monday, March 30th. The company reported ($0.09) EPS for the quarter. The company had revenue of $0.23 million during the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Itonic from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, June 5th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Itonic currently has a consensus rating of “Sell”.

Itonic Company Profile

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.